BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 26
• 29
• 30
• 31

• Drug Development

  Array BioPharma, Inc. Initiates MEK162 Phase 3 MILO Study Triggering Milestone Payment

  July 2, 2013

   · 

  5 min read
• Drug Development

  VentiRx Pharmaceuticals, Inc. Initiates the ACTIVE8 Phase 2 Clinical Trial Evaluating VTX-2337 in Combination With Cetuximab and Chemotherapy in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

  July 2, 2013

   · 

  3 min read
• Business

  Stevia First Corp. Signs With GRAS Associates for Product Regulatory Approval Process

  July 2, 2013

   · 

  4 min read
• Apogenix Strengthens Patent Position for Apocept™ (APG101) in Europe and Canada

  July 2, 2013

   · 

  5 min read
• Business

  Michael H. Kalnoski, M.D., Joins Atossa Genetics, Inc. as Medical Director

  July 2, 2013

   · 

  4 min read
• Bio NC

  Crown Marketing to Develop Oxycontin and Opioid Abuse Resistant Drug Device

  July 2, 2013

   · 

  2 min read
• Business

  Matthew G. Molchan Assumes the CEO Role at Digirad Corporation

  July 2, 2013

   · 

  2 min read
• Drug Development

  Galapagos NV Initiates Phase 1 Trial as Part of Its Alliance With Janssen Pharmaceutica N.V.

  July 2, 2013

   · 

  4 min read
• Novo Nordisk A/S - Share Repurchase Programme

  July 2, 2013

   · 

  1 min read
• Novo Nordisk A/S: Status Regarding Novo Nordisk’s Holding of Its Own Shares (30 June 2013)

  July 2, 2013

   · 

  1 min read